Time Bio Management

Time Bio Management

Time Bio Management, LLC was formed as a US-based limited liability company, a structure commonly used by family offices and investment vehicles to manage capital with legal and tax flexibility. The firm's name suggests a focus on biotechnology and life sciences, areas that have attracted significant private capital for drug development and medical innovation. The firm likely allocates capital across venture-stage biotechnology companies, private equity investments in healthcare services, and possibly public equities tied to the life sciences sector. Typical portfolio positions for such firms include early-stage therapeutic developers, diagnostic platforms, and companies leveraging AI for drug discovery. Geographic focus appears concentrated in the United States, particularly in major biotech hubs such as the San Francisco Bay Area, Boston, and San Diego. No publicly available data confirms the firm's assets under management, number of employees, or named principals. The structure as an LLC allows single-family offices to maintain privacy while managing direct investments, co-investments, and fund commitments. No recent operational events or team expansions have been reported in public sources. As a biotech-focused investment vehicle, Time Bio Management likely sources deals through industry networks, scientific advisory boards, and relationships with university technology transfer offices. The structural differentiator is its narrow sector focus on biotechnology, which requires specialized scientific and regulatory expertise atypical of diversified family offices.